IPHA
Innate Pharma·NASDAQ
--
--(--)
--
--(--)
3.60 / 10
Netural
Technical rating stands at 3.6/10 (neutral). A bullish Marubozu White pattern offers limited upside, while long lower and upper shadows generate bearish bias. Overall, bearish signals outnumber bullish ones, suggesting unclear direction and heightened volatility.
Analysis Checks(1/3)
Long Lower Shadow
Score2.22/10
Win Rate48.84%
Hist. Signals43
Avg Return-1.21%
Score2.22/10
Win Rate48.84%
Hist. Signals43
Avg Return-1.21%
Marubozu White
Score6.68/10
Win Rate56.25%
Hist. Signals32
Avg Return1.48%
Score6.68/10
Win Rate56.25%
Hist. Signals32
Avg Return1.48%
Long Upper Shadow
Score1.9/10
Win Rate43.48%
Hist. Signals46
Avg Return-0.25%
Score1.9/10
Win Rate43.48%
Hist. Signals46
Avg Return-0.25%
Long Lower Shadow
Score2.22/10
Win Rate48.84%
Hist. Signals43
Avg Return-1.21%
Score2.22/10
Win Rate48.84%
Hist. Signals43
Avg Return-1.21%
Long Upper Shadow
Score1.9/10
Win Rate43.48%
Hist. Signals46
Avg Return-0.25%
Score1.9/10
Win Rate43.48%
Hist. Signals46
Avg Return-0.25%
Marubozu White
Score6.68/10
Win Rate56.25%
Hist. Signals32
Avg Return1.48%
Score6.68/10
Win Rate56.25%
Hist. Signals32
Avg Return1.48%
Technical Analysis of IPHA?
- IPHA presents a Netural setup with a Technical Score of 3.60/10. Key technical indicators highlight an RSI of 38.80 and a MACD of -0.02, with the trend anchored by the 50-Day SMA at 1.62. Traders should monitor key support at 1.20 and resistance at 1.30.
